Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) Revenue (2016 - 2025)

Palisade Bio (PALI) has disclosed Revenue for 14 consecutive years, with -$5000.0 as the latest value for Q3 2025.

  • On a quarterly basis, Revenue changed N/A to -$5000.0 in Q3 2025 year-over-year; TTM through Sep 2025 was -$8000.0, a N/A change, with the full-year FY2023 number at $250000.0, changed N/A from a year prior.
  • Revenue was -$5000.0 for Q3 2025 at Palisade Bio, down from -$2000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $250000.0 in Q1 2023 to a low of -$1.7 million in Q1 2021.
  • A 3-year average of -$249166.7 and a median of -$3500.0 in 2025 define the central range for Revenue.
  • Biggest YoY gain for Revenue was 1140.0% in 2021; the steepest drop was 28521.93% in 2021.
  • Palisade Bio's Revenue stood at -$26000.0 in 2021, then soared by 1061.54% to $250000.0 in 2023, then crashed by 102.0% to -$5000.0 in 2025.
  • Per Business Quant, the three most recent readings for PALI's Revenue are -$5000.0 (Q3 2025), -$2000.0 (Q2 2025), and -$1000.0 (Q1 2025).